HB 379, extending the prohibition on PBMs to require federally certified health entities to identify 340B drug from June 1, 2023 to June 1, 2025, was amended and passed the House Business and Labor Committee on February 14.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.